Skip to main content
Premium Trial:

Request an Annual Quote

BioTools Gets Financing

Premium

EDMONTON, Alberta--BioTools announced that it secured a round of financing from private investment group Western New Ventures Capital. The University of Alberta spinoff, which was incorporated in 1996, said the funding would allow it to accelerate development and market entry of PepTool and GeneTool, its protein and DNA sequence analysis software products. BioTools said it would also be expanding its laboratory division.

Filed under

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.